![]() BIoEclipse Therapeutics BIoEclipse Therapeutics is a biopharmaceutical company developing curative immuno-oncology therapeutics. | ![]() Zymeworks Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics. | ![]() Neovii Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.
| ImmPACT-Bio ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy. | |
Founding Date | Founding Date N/A | Founding Date 2003 | Founding Date 2003 | Founding Date 2017 |
Type | Type Private | Type Public | Type Private | Type Private |
Tags | ||||
Locations | Locations South San Francisco, US HQ Mountain View, US | Locations Vancouver, CA HQ Seattle, US | Locations Rapperswil-Jona, CH HQ Gräfelfing, DE Lexington, US | Locations Camarillo, US HQ Rishon Le Tsiyon, IL |
Employees | Employees 614% decrease | Employees 45519% increase | Employees 1193% increase | Employees 845% decrease |
Funding | ||||
Latest funding round | Latest funding round $ 7.7m (almost 7 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 18m (almost 6 years ago) |
Total funding raised | Total funding raised $ 7.7m | Total funding raised $ 125.9m | Total funding raised N/A | Total funding raised $ 18m |

Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.
View company
Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.
View companyImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy.
View company